A point-of-care PCR test for HIV-1 detection in resource-limited settings

Area of Science:

• Medical Diagnostics
• Biotechnology
• Public Health

Background:

• Early infant diagnosis of Human Immunodeficiency Virus type 1 (HIV-1) is critical for initiating antiretroviral therapy.
• Current diagnostic methods often face challenges in resource-limited settings due to cost, complexity, and infrastructure requirements.

Purpose of the Study:

• To develop and validate a low-cost, integrated, sample-to-answer quantitative PCR (qPCR) system for point-of-care detection of HIV-1 proviral DNA in infants.
• To demonstrate the feasibility of a portable, battery-operated analyzer for use in resource-limited environments.

Main Methods:

• Development of a novel DNA extraction method utilizing a glass fiber membrane.
• Integration of reagent storage, thermal cycling, and fluorescence detection onto a disposable assay card.
• Automated PCR mix assembly and quantitative PCR (qPCR) using a novel reagent delivery system.
• Detection of HIV-1 and internal control targets using FAM and Quasar 670 fluorophores.

Main Results:

• Proof-of-concept demonstration of the integrated qPCR platform.
• Successful detection of HIV-1 in whole blood samples with concentrations greater than 5000 copies.
• The system is battery-operated and portable, suitable for point-of-care use.

Conclusions:

• The developed low-cost, integrated qPCR system shows promise for accurate HIV-1 detection in infants at the point-of-care.
• This technology has the potential to significantly improve access to diagnostic results in resource-limited settings.
• Facilitating earlier diagnosis can lead to timely initiation of antiretroviral therapy, improving infant health outcomes.